Bironzo P - Search Results

1

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.

Riganti C, Lingua MF, Salaroglio IC, Falcomatà C, Righi L, Morena D, Picca F, Oddo D, Kopecka J, Pradotto M, Libener R, Orecchia S, Bironzo P, Comunanza V, Bussolino F, Novello S, Scagliotti GV, Di Nicolantonio F, Taulli R. Riganti C, et al. Among authors: bironzo p. Oncoimmunology. 2017 Nov 27;7(3):e1398874. doi: 10.1080/2162402X.2017.1398874. eCollection 2018. Oncoimmunology. 2017. PMID: 29399399 Free PMC article.

2

HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy.

Yu HA, Goto Y, Hayashi H, Felip E, Chih-Hsin Yang J, Reck M, Yoh K, Lee SH, Paz-Ares L, Besse B, Bironzo P, Kim DW, Johnson ML, Wu YL, John T, Kao S, Kozuki T, Massarelli E, Patel J, Smit E, Reckamp KL, Dong Q, Shrestha P, Fan PD, Patel P, Sporchia A, Sternberg DW, Sellami D, Jänne PA. Yu HA, et al. Among authors: bironzo p. J Clin Oncol. 2023 Dec 10;41(35):5363-5375. doi: 10.1200/JCO.23.01476. Epub 2023 Sep 10. J Clin Oncol. 2023. PMID: 37689979 Free PMC article. Clinical Trial.

3

Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone.

Pia A, Vignani F, Attard G, Tucci M, Bironzo P, Scagliotti G, Arlt W, Terzolo M, Berruti A. Pia A, et al. Among authors: bironzo p. Cancer Treat Rev. 2013 Dec;39(8):966-73. doi: 10.1016/j.ctrv.2013.03.003. Epub 2013 Apr 10. Cancer Treat Rev. 2013. PMID: 23582279 Review.

4

Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer.

Carnio S, Novello S, Bironzo P, Scagliotti GV. Carnio S, et al. Among authors: bironzo p. Expert Rev Anticancer Ther. 2014 Dec;14(12):1495-513. doi: 10.1586/14737140.2014.949245. Epub 2014 Sep 3. Expert Rev Anticancer Ther. 2014. PMID: 25183305 Free article. Review.

5

Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.

Lo Iacono M, Monica V, Righi L, Grosso F, Libener R, Vatrano S, Bironzo P, Novello S, Musmeci L, Volante M, Papotti M, Scagliotti GV. Lo Iacono M, et al. Among authors: bironzo p. J Thorac Oncol. 2015 Mar;10(3):492-9. doi: 10.1097/JTO.0000000000000436. J Thorac Oncol. 2015. PMID: 25514803 Free article.

6

Addressing the unmet need in lung cancer: The potential of immuno-oncology.

Scagliotti GV, Bironzo P, Vansteenkiste JF. Scagliotti GV, et al. Among authors: bironzo p. Cancer Treat Rev. 2015 Jun;41(6):465-75. doi: 10.1016/j.ctrv.2015.04.001. Epub 2015 Apr 9. Cancer Treat Rev. 2015. PMID: 25936526 Free article. Review.

7

Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer.

Buttigliero C, Tucci M, Bertaglia V, Vignani F, Bironzo P, Di Maio M, Scagliotti GV. Buttigliero C, et al. Among authors: bironzo p. Cancer Treat Rev. 2015 Dec;41(10):884-92. doi: 10.1016/j.ctrv.2015.08.002. Epub 2015 Aug 31. Cancer Treat Rev. 2015. PMID: 26342718 Free article. Review.

8

Raising the bar for enthusiasm when looking at results of randomized phase II trials-the case of sunitinib in small-cell lung cancer.

Di Maio M, Bironzo P, Scagliotti GV. Di Maio M, et al. Among authors: bironzo p. Transl Lung Cancer Res. 2016 Feb;5(1):89-91. doi: 10.3978/j.issn.2218-6751.2015.07.18. Transl Lung Cancer Res. 2016. PMID: 26958498 Free PMC article.

9

Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer.

Leone G, Tucci M, Buttigliero C, Zichi C, Pignataro D, Bironzo P, Vignani F, Scagliotti GV, Di Maio M. Leone G, et al. Among authors: bironzo p. Endocr Relat Cancer. 2018 Jan;25(1):R1-R9. doi: 10.1530/ERC-17-0355. Epub 2017 Sep 28. Endocr Relat Cancer. 2018. PMID: 28971898 Free article. Review.

10

Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment?

Tampellini M, Bironzo P, Di Maio M, Scagliotti GV. Tampellini M, et al. Among authors: bironzo p. Future Oncol. 2018 May;14(12):1223-1231. doi: 10.2217/fon-2017-0627. Epub 2018 Apr 27. Future Oncol. 2018. PMID: 29701074 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters